In recent years, with the continuous deepening of research on obesity and related metabolic diseases, new intestinal insulinotropic drugs including glucagon like peptide-1 (GLP-1) agonists, dual glucose dependent insulinotropic peptides (GIP), and GLP-1 receptor agonists have gradually become a research hotspot in the medical field
The cost of a kidney transplant is $262,000 with $17,500 per year for anti-rejection drugs following the surgery, this equates to a total market of approximately $319.7 billion over a five-year period
Free coverage checker tools can clarify your benefits before you commit to a program or medication
There is a reason for that
Recently, medications known as GLP-1 agonists, including Ozempic, have become increasingly popular due to their ability to support meaningful weight loss, even among individuals without diabetes
Managing GLP-1 Side Effects Managing the side effects of GLP-1 medications is essential for maintaining long-term success in treatment